Search Page

1

Cite

Share

Sjogren's syndrome in optometric practices in North America.

Caffery B, Harthan J, Srinivasan S, Acs M, Barnett M, Edmonds C, Johnson-Tong L, Maharaj R, Pemberton B, Papinski D. Caffery B, et al. Among authors: acs m. Cont Lens Anterior Eye. 2018 Dec;41(6):518-526. doi: 10.1016/j.clae.2018.08.006. Epub 2018 Aug 18. Cont Lens Anterior Eye. 2018. PMID: 30131217

Cite

Share

2

Cite

Share

Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Acs M, Häusler S, Lighvani HR, Zustin J, Piso P. Acs M, et al. In Vivo. 2021 Nov-Dec;35(6):3591-3596. doi: 10.21873/invivo.12664. In Vivo. 2021. PMID: 34697200 Free PMC article.

Cite

Share

3

Cite

Share

The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI.

Kamada Y, Hida K, Yonemura Y, Sugarbaker PH, Ghabra S, Ishihara S, Nagata H, Murono K, Goi T, Katayama K, Morikawa M, Rau B, Piso P, Acs M, Coccolini F, Canbay E, Hsieh MC, Bhatt A, Bonnot PE, Glehen O. Kamada Y, et al. Among authors: acs m. Cancers (Basel). 2021 Jun 13;13(12):2964. doi: 10.3390/cancers13122964. Cancers (Basel). 2021. PMID: 34199234 Free PMC article.

Cite

Share

4

Cite

Share

Customary practices in the monitoring of dry eye disease in Sjogren's syndrome.

Acs M, Caffery B, Barnett M, Edmonds C, Johnson-Tong L, Maharaj R, Pemberton B, Papinski D, Harthan J, Srinivasan S. Acs M, et al. J Optom. 2018 Oct-Dec;11(4):232-241. doi: 10.1016/j.optom.2018.05.001. Epub 2018 Jul 17. J Optom. 2018. PMID: 30017867 Free PMC article.

Cite

Share

5

Cite

Share

Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review.

Acs M, Piso P, Prader S. Acs M, et al. Anticancer Res. 2022 Jan;42(1):13-24. doi: 10.21873/anticanres.15452. Anticancer Res. 2022. PMID: 34969704 Review.

Cite

Share

6

Cite

Share

Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Rajha A, Piso P, Halmy L, Panczel I, Nedelcut DS, Herold Z, Szasz AM, Acs M. Rajha A, et al. Among authors: acs m. Anticancer Res. 2022 Jul;42(7):3681-3692. doi: 10.21873/anticanres.15857. Anticancer Res. 2022. PMID: 35790287

Cite

Share

7

Cite

Share

Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.

Acs M, Leebmann H, Häusler S, Harter P, Piso P. Acs M, et al. In Vivo. 2022 Jan-Feb;36(1):341-349. doi: 10.21873/invivo.12708. In Vivo. 2022. PMID: 34972732 Free PMC article.

Cite

Share

8

Cite

Share

Selection Criteria for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Special Emphasis on Laparoscopy as an Efficient Tool.

Acs M, Dadras A, Blaj S, Leebmann H, Piso P. Acs M, et al. In Vivo. 2022 May-Jun;36(3):1367-1374. doi: 10.21873/invivo.12840. In Vivo. 2022. PMID: 35478130 Free PMC article.

Cite

Share

9

Cite

Share

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Acs M, Gerken M, Gajic I, Mayr M, Zustin J, Piso P. Acs M, et al. Langenbecks Arch Surg. 2022 Jun 23. doi: 10.1007/s00423-022-02594-6. Online ahead of print. Langenbecks Arch Surg. 2022. PMID: 35732846

Cite

Share

10

Cite

Share

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.

Acs M, Herold Z, Szasz AM, Mayr M, Häusler S, Piso P. Acs M, et al. Cancers (Basel). 2022 Jul 6;14(14):3301. doi: 10.3390/cancers14143301. Cancers (Basel). 2022. PMID: 35884361 Free PMC article.

Cite

Share